Idactamab INT-001 represents a interesting medicinal strategy for treating selected oncological cancers. The antibody shows an unique mode of action, mainly binding to CD38, a exterior protein expressed often on https://adamtoib085754.wikipublicity.com/8512414/idacta_mab_int_001_a_innovative_antigen_binding_protein_in_progression